Correlation Between Neurosense Therapeutics and Longeveron LLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurosense Therapeutics and Longeveron LLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurosense Therapeutics and Longeveron LLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurosense Therapeutics and Longeveron LLC, you can compare the effects of market volatilities on Neurosense Therapeutics and Longeveron LLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurosense Therapeutics with a short position of Longeveron LLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurosense Therapeutics and Longeveron LLC.

Diversification Opportunities for Neurosense Therapeutics and Longeveron LLC

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Neurosense and Longeveron is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Neurosense Therapeutics and Longeveron LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Longeveron LLC and Neurosense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurosense Therapeutics are associated (or correlated) with Longeveron LLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Longeveron LLC has no effect on the direction of Neurosense Therapeutics i.e., Neurosense Therapeutics and Longeveron LLC go up and down completely randomly.

Pair Corralation between Neurosense Therapeutics and Longeveron LLC

Given the investment horizon of 90 days Neurosense Therapeutics is expected to under-perform the Longeveron LLC. In addition to that, Neurosense Therapeutics is 1.2 times more volatile than Longeveron LLC. It trades about -0.12 of its total potential returns per unit of risk. Longeveron LLC is currently generating about -0.02 per unit of volatility. If you would invest  206.00  in Longeveron LLC on September 16, 2024 and sell it today you would lose (20.00) from holding Longeveron LLC or give up 9.71% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Neurosense Therapeutics  vs.  Longeveron LLC

 Performance 
       Timeline  
Neurosense Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurosense Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Longeveron LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Longeveron LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Longeveron LLC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Neurosense Therapeutics and Longeveron LLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurosense Therapeutics and Longeveron LLC

The main advantage of trading using opposite Neurosense Therapeutics and Longeveron LLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurosense Therapeutics position performs unexpectedly, Longeveron LLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Longeveron LLC will offset losses from the drop in Longeveron LLC's long position.
The idea behind Neurosense Therapeutics and Longeveron LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements